AstraZeneca’s Forxiga (dapagliflozin) Receives MHLW’s Approval for Chronic Heart Failure
Shots: Celltrion in collaboration with Poonglim Pharmatech will accelerate the development of its insulin pen biosimilar. The company will initiate the development of the insulin biosimilar in 2020 with an aim to commercially launch the product in 2025. Companies plans to develop a pen-type injection that can be administered up to 80 units at a […]Read More
